Mounjaros dual GIP and GLP-1 receptor activation provides more comprehensive metabolic effects compared to Wegovys single GLP-1 action
Why is my weight loss slower than the timeline shows
When food reaches the small intestine, hormones including GLP-1 are released which in turn enhances insulin secretion in the pancreas, slows gastric emptying and suppresses hunger by inhibiting the release of glucagon, a hormone involved in hunger regulation
Do not restrict access to a medication that is demonstrably superior and better tolerated for a significant portion of the patient population
Push the plunger slowly to administer the full dose
Emerging evidence suggests benefits in psychiatric conditions, including reduced addiction behaviors (e.g., to food, drugs, or alcohol) by dampening reward responses, alleviated depression symptoms via mood-regulating neurogenesis, and enhanced overall brain health through anti-inflammatory effects